A non-interventional observational study in adults assessing the safety and tolerability of AVANZ® in case of concomitant specific immunotherapy (SCIT/AIT/SLIT)

Trial Profile

A non-interventional observational study in adults assessing the safety and tolerability of AVANZ® in case of concomitant specific immunotherapy (SCIT/AIT/SLIT)

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Olea pollen allergy immunotherapy (Primary)
  • Indications Tree pollen hypersensitivity
  • Focus Adverse reactions
  • Sponsors ALK-Abello
  • Most Recent Events

    • 03 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top